The Impact of R&D Decisions on the Downstream Immunization System. Focus on the last mile access-to-medicines issues in low- and middle-income countries. KU Leuven
For many human infectious diseases, in particular for those caused by viruses for which no treatment is available, it is of utmost importance to have effective vaccines at hand. Prevention of suffering and death from infectious diseases by means of prophylactic vaccination is the most (cost-)effective public health intervention available today. However, for many pathogens no such vaccines exist. Many vaccines have features that impede their ...